These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 33268999)
1. Voretigene Neparvovec and Gene Therapy for Leber's Congenital Amaurosis: Review of Evidence to Date. Padhy SK; Takkar B; Narayanan R; Venkatesh P; Jalali S Appl Clin Genet; 2020; 13():179-208. PubMed ID: 33268999 [TBL] [Abstract][Full Text] [Related]
2. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis. Hussain RM; Tran KD; Maguire AM; Berrocal AM Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202 [TBL] [Abstract][Full Text] [Related]
3. Voretigene neparvovec-rzyl for treatment of Ciulla TA; Hussain RM; Berrocal AM; Nagiel A Expert Opin Biol Ther; 2020 Jun; 20(6):565-578. PubMed ID: 32149547 [No Abstract] [Full Text] [Related]
4. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy. Kang C; Scott LJ Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767 [TBL] [Abstract][Full Text] [Related]
5. [Gene therapy treatment based on an ophthalmic indication in hereditary retinal dystrophy caused by RPE65 biallelic gene mutation.]. Vizvári E; Smeller L; Jánossy Á; Lőrincz M; Janáky M; Tóth-Molnár E Orv Hetil; 2022 Nov; 163(48):1923-1931. PubMed ID: 36436058 [TBL] [Abstract][Full Text] [Related]
6. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials. Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102 [TBL] [Abstract][Full Text] [Related]
7. Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis. Gange WS; Sisk RA; Besirli CG; Lee TC; Havunjian M; Schwartz H; Borchert M; Sengillo JD; Mendoza C; Berrocal AM; Nagiel A Ophthalmol Retina; 2022 Jan; 6(1):58-64. PubMed ID: 33838313 [TBL] [Abstract][Full Text] [Related]
8. [Implementation of a new gene therapy in ophthalmology: Regulatory and organizational issues]. Daruich A; Boinet R; Falcou C; Cotteret C; Magassa A; Schlatter J; Escalup R; Cisternino S; Valleix S; Robert MP; Bremond-Gignac D J Fr Ophtalmol; 2021 May; 44(5):730-737. PubMed ID: 33838946 [TBL] [Abstract][Full Text] [Related]
9. Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee. Han J; Joo K; Kim US; Woo SJ; Lee EK; Lee JY; Park TK; Kim SJ; Byeon SH Korean J Ophthalmol; 2023 Apr; 37(2):166-186. PubMed ID: 36950921 [TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis. Gerhardt MJ; Priglinger CS; Rudolph G; Hufendiek K; Framme C; Jägle H; Salchow DJ; Anschütz A; Michalakis S; Priglinger SG Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672611 [TBL] [Abstract][Full Text] [Related]
11. Current Management of Patients with RPE65 Mutation-Associated Inherited Retinal Degenerations in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network. Lorenz B; Tavares J; van den Born LI; Marques JP; Scholl HPN; Ophthalmic Res; 2021; 64(5):740-753. PubMed ID: 33684911 [TBL] [Abstract][Full Text] [Related]
12. Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence. Gao J; Hussain RM; Weng CY Clin Ophthalmol; 2020; 14():3855-3869. PubMed ID: 33223822 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy for inherited retinal diseases. Nuzbrokh Y; Ragi SD; Tsang SH Ann Transl Med; 2021 Aug; 9(15):1278. PubMed ID: 34532415 [TBL] [Abstract][Full Text] [Related]
14. Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting. Lorenz B; Künzel SH; Preising MN; Scholz JP; Chang P; Holz FG; Herrmann P Ophthalmology; 2024 Feb; 131(2):161-178. PubMed ID: 37704110 [TBL] [Abstract][Full Text] [Related]
15. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia]. Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591 [TBL] [Abstract][Full Text] [Related]
16. Leber's congenital amaurosis and the role of gene therapy in congenital retinal disorders. Sharif W; Sharif Z Int J Ophthalmol; 2017; 10(3):480-484. PubMed ID: 28393043 [TBL] [Abstract][Full Text] [Related]
17. The first gene therapy for Ferraz Sallum JM; Godoy J; Kondo A; Kutner JM; Vasconcelos H; Maia A Ophthalmic Genet; 2022 Aug; 43(4):550-554. PubMed ID: 35416119 [TBL] [Abstract][Full Text] [Related]